Senators Collins, King Announce Nearly $500,000 Awarded to Jackson Lab for Diabetes, Endocrinology, & Metabolic Research

Washington, D.C.  – U.S. Senators Susan Collins (R-ME) and Angus King (I-ME) announced that The Jackson Laboratory (JAX) in Bar Harbor has received $436,249 from the Department of Health and Human Services (DHHS) for diabetes, endocrinology, and metabolic research.  This funding was awarded through DHHS’ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).  Senator Collins is the founder and co-chair of the Senate Diabetes Caucus and the Chairman of the Senate Aging Committee. 

 

“The important work being done at The Jackson Laboratory is making great strides to conquer diseases that affect nearly every American family,” said Senators Collins and King in a joint statement.  “We welcome this continued funding to help support JAX’s efforts to understand, treat, and one day cure diabetes and other endocrine and metabolic diseases.”

 

The Jackson Laboratory is an independent, nonprofit biomedical research institution based in Bar Harbor, Maine, with a National Cancer Institute-designated Cancer Center, a facility in Sacramento, Calif., and a genomic medicine institute in Farmington, Conn.  It employs 1,900 staff, and its mission is to discover precise genomic solutions for disease and empower the global biomedical community in the shared quest to improve human health.

 

NIDDK research supports treatments for diseases that are among the most chronic, costly, and consequential for patients, their families, and the nation.